Equity Overview
Price & Market Data
Price: $0.805
Daily Change: -$0.005 / 0.62%
Range: $0.756 - $0.816
Market Cap: $62,796,236
Volume: 229,234
Performance Metrics
1 Week: 6.33%
1 Month: -9.25%
3 Months: -7.13%
6 Months: -21.54%
1 Year: -33.76%
YTD: -14.94%
Company Details
Employees: 32
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide injectable suspension for the treatment of macular edema associated with uveitis. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which has completed Phase 2 clinical trial to treat wet AMD. The company has a collaboration with bausch + lomb ireland limited, Arctic Vision (Hong Kong) Limited, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences, Inc. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.